NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Soft tissue sarcoma
Date of first enrollment	22/06/2010
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : ET-743 INN of investigational material : trabectedin Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : intravenous administration, One of three doses; 0.9mg/m2, 1.2mg/m2, 1.5mg/m2 (Based on the body surface area).

Outcome(s)

Primary Outcome	Safety
Secondary Outcome	Pharmacokinetics, Safety, Efficacy

Key inclusion & exclusion criteria

Age minimum	>= 18age old
Age maximum	Not applicable
Gender	Both
Include criteria	1)Patients who have a histologically confirmed soft tissue sarcoma. 2)Patients who have failed the standard therapy. 3)Others.
Exclude criteria	1)Serious concomitant illness. 2)Prior therapy-related toxicity. 3)Others.